Tag Archives: pharmacy practice
Under a new statewide protocol based on Senate Bill 16-135, only Colorado-licensed pharmacists that have completed an Accreditation Council for Pharmacy Education (ACPE) accredited educational training program related to the prescribing of contraceptives by a pharmacist, may dispense hormonal contraceptive patches and oral hormone contraceptives to patients who are at least 18 years of age.
Additionally, for new patients requesting contraceptive services, a participating pharmacist must:
- Obtain a completed Colorado Self-Screening Risk Assessment Questionnaire;
- Utilize and follow the Colorado Standard Procedures Algorithm to perform the patient assessment;
- Prescribe, if clinically appropriate, the hormonal contraceptive patch or self-administered oral hormonal contraceptive, or refer to a healthcare practitioner;
- Provide the patient with a Visit Summary;
- Advise the patient to consult with a primary care practitioner or women’s health care practitioner;
- Refer any patient that may be subject to abuse to an appropriate social services agency; and
- Ensure that the pharmacy provides appropriate space to prevent the spread of infection and ensure confidentiality.
Colorado Board of Pharmacy Approved Protocols include:
Hormonal Contraception Protocol A (includes Standard Procedures Algorithm and the Self-Screening Risk Assessment Questionnaire)
Smoking Cessation: currently being addressed the Colorado Board of Pharmacy (watch for updates)
Earlier this year, the Louisiana Board of Pharmacy (Louisiana Board) exercised the emergency provision of the Louisiana Administrative Procedure Act (R.S. 49:9.53.B), to amend its rules governing the compounding of drugs by pharmacies and restored the capability for pharmacies to compound drugs intended for the administration by veterinarians without the necessity of a patient-specific prescription.
As previously discussed at length on the Baer Law Blog, after the passage of the Drug Quality and Security Act (DQSA) of 2013, many state boards of pharmacy amended their rules regarding to address compounded medications and adopted rules requiring patient-specific prescriptions. However, the Food and Drug Administration (FDA), in clarifying the DQSA, stated the DQSA only applies to compounding drugs for human use and does not apply to the compounding of drugs for animal use.
The Louisiana Board, after reviewing requests from veterinarians and many other concerned organizations regarding the dire need for emergency use veterinary compounded drugs, recently restored the authority for pharmacies to compound drugs for office use by veterinarians only, and not for human use.
Through its emergency rule, which the Louisiana Board cited its desire to prevent imminent peril to the public health, safety and welfare, the Louisiana Board granted the temporary authority for pharmacies to compound medications for office use by veterinarians. Per the Louisiana Board, the emergency declaration remains in effect until for the maximum time period allowed under the Administrative Procedure Act or until the adoption of the final rule, whichever occurs first.
The new temporary Louisiana Board rules can be found under §2535.
Earlier this month, California Governor Jerry Brown signed a new California law that seeks to expand the scope of pharmacy practice within California and improve patient access to care. The bill would establish board recognition for advanced practice pharmacists who, starting January 1, 2014, will be able to perform the following tasks:
- Perform patient assessments;
- Order and interpret drug therapy-related laboratory tests;
- Refer patients to other providers;
- Initiate, adjust, and discontinue medications under physician protocol;
- Work with other health care providers to evaluate and manage a patient’s health issues.
The law, SB 493, seeks to proactively address a growing shortage in primary care providers that is projected to increase with the expansion of the state’s Medi-Cal program under the federal Patient Protection and Affordable Care Act.